Preclinical study of goat milk kefir as an antihyperglycemic food

Authors

  • Siti Susanti Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Nurwantoro Nurwantoro Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Jessen Juan Elto Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia
  • Trilaksana Nugroho Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Ade Erma Suryani Research Center for Food Technology and Processing-National Research and Innovation Agenc
  • Heni Rizqiati Food Technology, Department of Agriculture, Faculty of Animal Sciences and Agriculture, Diponegoro University, Semarang, Indonesia

DOI:

https://doi.org/10.31989/ffhd.v12i12.987

Abstract

Background: Goat milk kefir is a functional food with numerous health benefits, including blood sugar control, cholesterol reduction, and improved digestive health. This study aims to determine the effect of kefir consumption on blood glucose levels in hyperglycaemic mice (Mus musculus) without affecting another blood chemistry.  This study compared goat milk kefir products to other processed milk products considered to be capable of controlling and reducing blood sugar levels. 

Objective:This study aimed to compare goat milk kefir products to other processed food products considered to be capable of controlling and reducing blood sugar levels.

Methods: Twenty-one mice, as experimental animals, were induced for 21 days with the high-fat and high fructose diet to increase blood sugar levels. After induction, mice were divided into 3 groups according to treatment, namely oral administration of additional distilled water (placebo), diabetasol® (positive control), and goat's milk kefir with each group consisting of 9 individuals. 

Results: Treatment showed significant effect on the blood glucose and β-ketone level. Diabetasol®  and Goat kefir supplemented mice had a lower blood glucose level than control (p < 0.05) and goat kefir supplemented mice had lower blood β-ketone level than control and Diabetasol® (p< 0.05). Meanwhile, hematocrit and hemoglobin levels did not show significant differences between treatments.

Conclusion: The results suggested that goat milk kefir has preclinical potential as an antihyperglycemic functional food without affecting other blood chemistry profiles.

Keywords: Antihyperglycemic, blood sugar, goat kefir

Downloads

Published

2022-12-08

Issue

Vol. 12 No. 12 (2022): December 2022

Section

Research Articles

License

Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.